7-21902051-A-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_018719.5(CDCA7L):c.*271T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.341 in 468,818 control chromosomes in the GnomAD database, including 28,511 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.34 ( 8858 hom., cov: 34)
Exomes 𝑓: 0.34 ( 19653 hom. )
Consequence
CDCA7L
NM_018719.5 3_prime_UTR
NM_018719.5 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.0430
Publications
10 publications found
Genes affected
CDCA7L (HGNC:30777): (cell division cycle associated 7 like) Acts upstream of or within positive regulation of cell population proliferation. Located in cytosol; fibrillar center; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
DNAH11 (HGNC:2942): (dynein axonemal heavy chain 11) This gene encodes a ciliary outer dynein arm protein and is a member of the dynein heavy chain family. It is a microtubule-dependent motor ATPase and has been reported to be involved in the movement of respiratory cilia. Mutations in this gene have been implicated in causing Kartagener Syndrome (a combination of situs inversus totalis and Primary Ciliary Dyskinesia (PCD), also called Immotile Cilia Syndrome 1 (ICS1)) and male sterility. [provided by RefSeq, Mar 2013]
DNAH11 Gene-Disease associations (from GenCC):
- primary ciliary dyskinesia 7Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.372 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CDCA7L | NM_018719.5 | c.*271T>G | 3_prime_UTR_variant | Exon 10 of 10 | ENST00000406877.8 | NP_061189.2 | ||
| CDCA7L | NM_001127370.3 | c.*271T>G | 3_prime_UTR_variant | Exon 11 of 11 | NP_001120842.1 | |||
| CDCA7L | NM_001127371.3 | c.*271T>G | 3_prime_UTR_variant | Exon 9 of 9 | NP_001120843.1 | |||
| DNAH11 | NM_001277115.2 | c.*797A>C | downstream_gene_variant | ENST00000409508.8 | NP_001264044.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.337 AC: 51181AN: 151998Hom.: 8861 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
51181
AN:
151998
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.343 AC: 108606AN: 316702Hom.: 19653 Cov.: 3 AF XY: 0.339 AC XY: 56317AN XY: 166012 show subpopulations
GnomAD4 exome
AF:
AC:
108606
AN:
316702
Hom.:
Cov.:
3
AF XY:
AC XY:
56317
AN XY:
166012
show subpopulations
African (AFR)
AF:
AC:
2802
AN:
9962
American (AMR)
AF:
AC:
4651
AN:
14532
Ashkenazi Jewish (ASJ)
AF:
AC:
4503
AN:
9856
East Asian (EAS)
AF:
AC:
4070
AN:
23002
South Asian (SAS)
AF:
AC:
7824
AN:
29436
European-Finnish (FIN)
AF:
AC:
7097
AN:
18770
Middle Eastern (MID)
AF:
AC:
474
AN:
1380
European-Non Finnish (NFE)
AF:
AC:
70628
AN:
191160
Other (OTH)
AF:
AC:
6557
AN:
18604
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
3290
6580
9869
13159
16449
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
384
768
1152
1536
1920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.336 AC: 51175AN: 152116Hom.: 8858 Cov.: 34 AF XY: 0.333 AC XY: 24782AN XY: 74332 show subpopulations
GnomAD4 genome
AF:
AC:
51175
AN:
152116
Hom.:
Cov.:
34
AF XY:
AC XY:
24782
AN XY:
74332
show subpopulations
African (AFR)
AF:
AC:
11846
AN:
41496
American (AMR)
AF:
AC:
4940
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
1620
AN:
3472
East Asian (EAS)
AF:
AC:
939
AN:
5174
South Asian (SAS)
AF:
AC:
1254
AN:
4822
European-Finnish (FIN)
AF:
AC:
3988
AN:
10550
Middle Eastern (MID)
AF:
AC:
97
AN:
294
European-Non Finnish (NFE)
AF:
AC:
25535
AN:
67994
Other (OTH)
AF:
AC:
710
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1797
3594
5391
7188
8985
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
498
996
1494
1992
2490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
789
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.